Inventor
John Lincecum
Inventor
Jamaica Plain, MA, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C07CAcyclic or carbocyclic compounds5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
11,014,990Anti-CD40L antibodies202110,683,356Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies202010,106,618Anti-CD40L antibodies20189,775,899'Treating neurological disorders'20179,044,459'Method for the treatment of neurodegenerative diseases'20158,946,301'Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis'20158,673,308'Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases'20148,435,514'Method for the treatment of neurodegenerative diseases'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2015Patents assigned to ALS THERAPY DEV INST (4)· patent assignee history
2013–2014Patents assigned to GILL ALAN (2)· patent assignee history
2013–2014Patents assigned to PERRIN STEVEN (2)· patent assignee history
2013–2014Patents assigned to VIEIRA FERNANDO (2)· patent assignee history
2013–2021Based in Jamaica Plain, MA, US· patent location history
2018–2021Patents assigned to ALS THERAPY DEVELOPMENT INST (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALS THERAPY DEV INST | 4 | 2013–2015 |
| ALS THERAPY DEVELOPMENT INST | 3 | 2018–2021 |
| GILL ALAN | 2 | 2013–2014 |
| PERRIN STEVEN | 2 | 2013–2014 |
| VIEIRA FERNANDO | 2 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Jamaica Plain, Massachusetts, US | 8 | 2013–2021 |